Predicting the outcome of ankylosing spondylitis therapy

Predicting the outcome of ankylosing spondylitis therapy

Objectives To create a model that provides a potential basis for candidate selection for anti-tumour necrosis factor (TNF) treatment by predicting future outcomes relative to the current disease profile of individual patients with ankylosing spondylitis (AS). Methods ASSERT and GO–RAISE trial data (...

Mô tả đầy đủ

Đã lưu trong:

Chi tiết về thư mục
Những tác giả chính:	Nathan Vastesaeger, Désirée van der Heijde, Robert D. Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U. Rahman, Ben A. C. Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes‐Estévez, Joachim Sieper, Jürgen Braun
Định dạng:	Artigo
Ngôn ngữ:	Tiếng Anh
Được phát hành:	2011
Truy cập trực tuyến:	https://doi.org/10.1136/ard.2010.147744 https://ard.bmj.com/content/annrheumdis/70/6/973.full.pdf
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Những quyển sách tương tự

Predicting the outcome of ankylosing spondylitis therapy
Bằng: Vastesaeger, Nathan, et al.
Được phát hành: (2011)

Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery
Bằng: Bert Vander Cruyssen, et al.
Được phát hành: (2009)

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
Bằng: van der Heijde, Désirée, et al.
Được phát hành: (2019)

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
Bằng: Désirée van der Heijde, et al.
Được phát hành: (2018)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
Bằng: Braun, Jürgen, et al.
Được phát hành: (2011)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
Bằng: Jürgen Braun, et al.
Được phát hành: (2011)

Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab
Bằng: Wagner, Carrie, et al.
Được phát hành: (2011)

Ankylosing spondylitis: an overview
Bằng: Joachim Sieper, et al.
Được phát hành: (2002)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Bằng: Deodhar, Atul, et al.
Được phát hành: (2015)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Bằng: Atul Deodhar, et al.
Được phát hành: (2014)

Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience
Bằng: Braun, J, et al.
Được phát hành: (2002)

The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
Bằng: Désirée van der Heijde, et al.
Được phát hành: (2014)

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Bằng: Dominique Baeten, et al.
Được phát hành: (2015)

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
Bằng: Jürgen Braun, et al.
Được phát hành: (2005)

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
Bằng: Jürgen Braun, et al.
Được phát hành: (2011)

Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
Bằng: Jürgen Braun, et al.
Được phát hành: (2023)

Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study
Bằng: Inman, Robert D., et al.
Được phát hành: (2016)

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
Bằng: Xenofon Baraliakos, et al.
Được phát hành: (2023)

The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Bằng: Braun, Jürgen, et al.
Được phát hành: (2014)

The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
Bằng: Jürgen Braun, et al.
Được phát hành: (2013)

The epidemiology of ankylosing spondylitis and the commencement of anti‐TNF therapy in daily rheumatology practice
Bằng: Cruyssen, Bert Vander, et al.
Được phát hành: (2007)

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
Bằng: Bert Vander Cruyssen, et al.
Được phát hành: (2007)

Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome
Bằng: Annelies Boonen, et al.
Được phát hành: (2009)

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies
Bằng: Braun, Jürgen, et al.
Được phát hành: (2018)

The epidemiology of osteoporosis and fractures in ankylosing spondylitis
Bằng: Sambrook, Philip N., et al.
Được phát hành: (2012)

The epidemiology of osteoporosis and fractures in ankylosing spondylitis
Bằng: Philip N. Sambrook, et al.
Được phát hành: (2012)

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study
Bằng: Braun, Jürgen, et al.
Được phát hành: (2011)

ASAS/EULAR recommendations for the management of ankylosing spondylitis
Bằng: Zochling, J, et al.
Được phát hành: (2006)

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
Bằng: Désirée van der Heijde, et al.
Được phát hành: (2022)

Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis
Bằng: Ben A. C. Dijkmans, et al.
Được phát hành: (2009)

Ankylosing spondylitis: an overview
Bằng: Sieper, J, et al.
Được phát hành: (2002)

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
Bằng: Sudha Visvanathan, et al.
Được phát hành: (2008)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Bằng: Braun, J, et al.
Được phát hành: (2011)

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.
Bằng: Jürgen Braun, et al.
Được phát hành: (2002)

Definition of disease duration in ankylosing spondylitis: reassessing the concept
Bằng: Davis, J C, et al.
Được phát hành: (2006)

Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis
Bằng: Désirée van der Heijde, et al.
Được phát hành: (2007)

Staging of patients with ankylosing spondylitis: a preliminary proposal
Bằng: Braun, J, et al.
Được phát hành: (2002)

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
Bằng: Désirée van der Heijde, et al.
Được phát hành: (2008)

Determinants of hyperkyphosis in patients with ankylosing spondylitis
Bằng: Vosse, D, et al.
Được phát hành: (2006)

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
Bằng: Jürgen Braun, et al.
Được phát hành: (2016)